Carelabs Co., Ltd.

Carelabs Co., Ltd.

KKRX:263700
1,990.00
KRW
+9.00
(+0.45%)
-343.67EPS
39.87BMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
572,155.72
7,431.15
4,498.46
4,757.91
2,696.35
5,100.33
5,472.99
4,879.38
4,310.33
4,286.52
4,212.68
3,816.18
Basic EPS, GAAP
63,825.09
773
547.5
311
23
288
73
-1,455
-1,289
-1,045
989
-376.6
Free Cash Flow per Basic Share
23,484.16
874.33
168.11
-1,285.54
74.37
634.62
36.33
-576.15
-660.36
-225.54
-789.04
-1,196.33
Dividend per Share
- -
- -
- -
- -
- -
19.56
- -
27.29
25.81
25.25
26.51
1.24
Book Value per Share
192.14
1,121.46
2,529.66
4,842.7
4,898.78
5,688.89
5,939.25
4,648.47
3,532.56
2,497.09
3,530.7
3,438.93
Tangible Book Value per Share
191.88
142.76
484.04
2,240.38
2,046.69
3,787.75
3,965
3,391.59
2,570.39
1,843.25
2,894.54
2,812.2
Basic Weighted Avg Shares
- -
3
9
11
25
15
17
18
19
19
19
19
Sales/Revenue/Turnover
11,443
18,597
39,336
54,379
68,300
76,666
93,934
87,607
81,827
83,187
81,694
74,006
Operating Margin (%)
11.51
11.16
15.9
9.33
5.29
7.77
3.49
-7.02
-14.17
-5.36
-3.52
-8.57
Depreciation Expense
10
102
602
1,205
2,312
2,568
2,821
4,030
4,426
3,655
2,919
2,711
Net Income, GAAP
1,277
1,935
4,788
3,554
583
4,329
1,253
-26,124
-24,470
-20,280
19,179
-7,303
Effective Tax Rate (%)
7.7
8.25
15.37
9.79
- -
27.07
68.45
- -
- -
- -
16.72
- -
Profit Margin (%)
11.16
10.4
12.17
6.54
0.85
5.65
1.33
-29.82
-29.9
-24.38
23.48
-9.87
Working Capital
1,679
310
8,096
36,924
3,859
47,028
39,460
77,508
67,237
14,626
20,416
15,933
LT Debt
- -
- -
4,236
44,434
14,734
13,498
51,942
39,924
33,643
3,221
1,662
888
Total Equity
1,782
10,404
26,872
64,019
67,472
103,218
107,955
91,577
75,066
54,978
74,631
72,682
Return on Invested Capital (%)
- -
27.1
22.78
6.14
- -
3.68
0.68
- -
- -
- -
-2.64
- -
Return on Capital (%)
- -
30.38
20.45
5.34
- -
4.17
1.15
- -
- -
- -
22.03
- -
Return on Common Equity (%)
- -
31.75
28.27
8.54
0.96
5.4
1.25
-27.95
-31.96
-34.67
32.8
-10.46

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,647
1,646
1,647
LT Borrowings
- -
- -
- -
LT Finance Leases
1,662
1,231
888
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
19
19
19
Market Capitalization
57,036
44,426
39,867

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
50,487
43,616
39,908
Cash, Cash Equivalents & STI
44,315
38,074
34,792
Accounts Receivable, Net
3,732
2,783
2,122
Inventories
44
97
259
Total Current Liabilities
30,071
25,725
23,975
Payables & Accruals
- -
- -
- -
ST Debt
1,647
1,646
1,647
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
81.9%
-3.92%
35.75%
Free Cash Flow
-211.96%
-329.35%
249.59%
Net Income, GAAP
-174.14%
-494.83%
-194.57%
Sales/Revenue/Turnover
25.92%
1.81%
-1.79%
Total Cash Common Dividend
- -
- -
4.92%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
22,364
19,378
19,425
22,021
83,187
2025
23,065
22,522
21,158
14,949
81,694
2026
20,538
17,361
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
126
-255
-155
-606.75
-1,045
2025
1,307
-45
-66.87
-206.38
989
2026
-31.32
-72
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
25.25
2025
25.26
- -
- -
1.24
26.51
2026
- -
- -
- -
- -
- -

Company Description

CEO
Min-Gyeong Lee
Full Time Employees
125
Sector
Technology services
Industry
Packaged software
Address
Seoul South Korea
IPO Date
Mar 28, 2018
Business
Carelabs Co., Ltd. is a South Korea-based digital healthcare and beauty platform company that specializes in medical information technology, digital marketing, and health-tech software solutions. Founded in 2012 and headquartered in Seoul, South Korea, the company operates across three primary business segments: Healthcare Media, Beauty Care, and Healthcare IT Solutions. The company's core product and service offerings include Goodoc, an online-to-offline mobile healthcare platform that provides hospital and pharmacy search directories, real-time appointment booking, remote telemedicine consultations, digital prescription management, and health checkup scheduling; Babitalk, a specialized aesthetic and plastic surgery information platform offering user-generated clinical reviews, surgical cost comparisons, promotional information, and direct consultation booking with dermatology and plastic surgery clinics; digital performance marketing, advertising agency services, and customized content creation solutions for healthcare providers, pharmaceutical companies, and medical aesthetic institutions; and enterprise healthcare IT solutions, including Electronic Medical Record software, cloud-based Customer Relationship Management systems for private clinics and pharmacies, and automated medical check-in kiosk infrastructure. In recent developments, Carelabs underwent a major ownership transition following its acquisition by the Wonik Group consortium, which established Wonik Cube as its largest controlling shareholder to foster operational synergies across medical technology and advanced healthcare solutions. To enhance capital efficiency and operational agility, the company restructured its core platform operations by establishing dedicated operating subsidiaries for Goodoc and Babitalk, while accelerating the international expansion of Babitalk into overseas beauty markets, including Japan and Southeast Asia. Additionally, Carelabs continues to scale its digital health ecosystem through strategic partnerships with domestic medical institutions, incorporating artificial intelligence into its clinical appointment and diagnostic assistance platforms, and expanding its non-face-to-face medical service capabilities across South Korea.